Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Duployez

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Hemasphere|January 6, 2025
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidineFrancesca Tiso, Florentien E M In 't Hout, Ruth Knops, et al.
Blood Advances|May 8, 2020
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study resultsClaude Gardin, Cécile Pautas, Elise Fournier, et al.
Blood Advances|October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availabilityMarie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
European Journal of Human Genetics : EJHG|October 3, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriersMarie-Charlotte Villy, Youenn Drouet, Lise Larcher, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Frontiers in Oncology|January 11, 2020
B-ALL With t(5;14)(q31;q32); <i>IGH-IL3</i> Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar <i>IGH</i>-Rearranged B-ALLBenjamin Fournier, Estelle Balducci, Nicolas Duployez, et al.
Hemasphere|June 17, 2026
<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemiaRathana Kim, Marie Passet, Hugo Bergugnat, et al.
Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Blood|April 21, 2021
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA studyMatthieu Duchmann, Jean-Baptiste Micol, Nicolas Duployez, et al.
Hemasphere|January 6, 2025
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidineFrancesca Tiso, Florentien E M In 't Hout, Ruth Knops, et al.
Blood Advances|May 8, 2020
Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study resultsClaude Gardin, Cécile Pautas, Elise Fournier, et al.
Blood Advances|October 8, 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availabilityMarie Sebert, Sylvain Thepot, Thomas Cluzeau, et al.
European Journal of Human Genetics : EJHG|October 3, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriersMarie-Charlotte Villy, Youenn Drouet, Lise Larcher, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Frontiers in Oncology|January 11, 2020
B-ALL With t(5;14)(q31;q32); <i>IGH-IL3</i> Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar <i>IGH</i>-Rearranged B-ALLBenjamin Fournier, Estelle Balducci, Nicolas Duployez, et al.
Hemasphere|June 17, 2026
<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemiaRathana Kim, Marie Passet, Hugo Bergugnat, et al.
Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.
Pageof 15